Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose This study was conducted to evaluate the long-term outcome in patients undergoing pancreaticoduodenectomy (PD) followed by adjuvant chemoradiotherapy for distal cholangiocarcinoma (DCC) in a high-volume center and to identify the prognostic impact of clinicopathologic factors. Materials and Methods A total of 132 consecutive patients who met the inclusion criteria were retrieved from the institutional database from January 1995 to September 2009. All patients received adjuvant treatments at a median of 45 days after the surgery. Median follow-up duration was 57 months (range, 6 to 225 months) for all patients and 105 months for survivors (range, 13 to 225 months). Results The 5-year locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS) rates were 70.7%, 55.7%, 49.4%, and 48.1%, respectively. Univariate analysis revealed poorly differentiated (P/D) tumors and lymph node (LN) metastasis were significantly associated with DMFS and OS. Additionally, preoperative carbohydrate antigen 19-9 level was significantly correlated with DFS, LRRFS, and DMFS. Upon multivariate analysis for OS, P/D tumors (p=0.015) and LN metastasis (p=0.003) were significant prognosticators that predicted inferior OS. Grade 3 or higher late gastrointestinal toxicity occurred in only one patient (0.8%). Conclusion Adjuvant chemoradiotherapy after PD for DCC is an effective and tolerable strategy without significant side effects. During long-term follow-up, we found that prognosis of DCC was mainly influenced by histologic differentiation and LN metastasis. For patients with these risk factors, further research should focus on improving adjuvant strategies as well as other treatment approaches.
Abstract
Purpose This study was conducted to evaluate the long-term outcome in patients undergoing pancreaticoduodenectomy (PD) followed by adjuvant chemoradiotherapy for distal cholangiocarcinoma (DCC) in a high-volume center and to identify the prognostic impact of clinicopathologic factors. Materials and Methods A total of 132 consecutive patients who met the inclusion criteria were retrieved from the institutional database from January 1995 to September 2009. All patients received adjuvant treatments at a median of 45 days after the surgery. Median follow-up duration was 57 months (range, 6 to 225 months) for all patients and 105 months for survivors (range, 13 to 225 months). Results The 5-year locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS) rates were 70.7%, 55.7%, 49.4%, and 48.1%, respectively. Univariate analysis revealed poorly differentiated (P/D) tumors and lymph node (LN) metastasis were significantly associated with DMFS and OS. Additionally, preoperative carbohydrate antigen 19-9 level was significantly correlated with DFS, LRRFS, and DMFS. Upon multivariate analysis for OS, P/D tumors (p=0.015) and LN metastasis (p=0.003) were significant prognosticators that predicted inferior OS. Grade 3 or higher late gastrointestinal toxicity occurred in only one patient (0.8%). Conclusion Adjuvant chemoradiotherapy after PD for DCC is an effective and tolerable strategy without significant side effects. During long-term follow-up, we found that prognosis of DCC was mainly influenced by histologic differentiation and LN metastasis. For patients with these risk factors, further research should focus on improving adjuvant strategies as well as other treatment approaches.
참고문헌 (29)
- 오창모, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013", Cancer Research and Treatment, 48(2), pp.436~450 (2016), 대한암학회
- Andrianello S, "Pancreaticoduodenectomy for distal cholangiocarcinoma : surgical results, prognostic factors, and longterm follow-up", Langenbecks Arch Surg, 400, pp.623~628 (2015)
- Tae Ryool Koo, "Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy", Radiation oncology journal, 32(2), pp.63~69 (2014), 대한방사선종양학회
- Kim HJ, "Prognostic factors for survival after curative resection of distal cholangiocarcinoma : perineural invasion and lymphovascular invasion", Surg Today, 44, pp.1879~1886 (2014)
- Tan X, "Prognostic factors of distal cholangiocarcinoma after curative surgery : a series of 84 cases", Hepatogastroenterology, 60, pp.1892~1895 (2013)
- van der Gaag NA, "Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma", Ann Oncol, 23, pp.2642~2649 (2012)
- Kamposioras K, "Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer", Br J Surg, 101, pp.89~99 (2014)
- Kim K, "Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer", Int J Radiat Oncol Biol Phys, 84, pp.81~87 (2012)
- Miyakawa S, "Biliary tract cancer treatment : 5, 584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004in Japan", J Hepatobiliary Pancreat Surg, 16, pp.1~7 (2009)
- Nakeeb A, "Cholangiocarcinoma : a spectrum of intrahepatic, perihilar, and distal tumors", Ann Surg, 224, pp.463~473 (1996)
- Kwon HJ, "Prognostic factors in patients with middle and distal bile duct cancers", World J Gastroenterol, 20, pp.6658~6665 (2014)
- Wiltberger G, "Prognostic accuracy of the seventh edition of the TNM classification compared with the fifth and sixth edition for distal cholangiocarcinoma", Ann Surg Oncol, 23, pp.1320~1326 (2016)
- Zhou Y, "Survival after surgical resection of distal cholangiocarcinoma : a systematic review and metaanalysis of prognostic factors", Asian J Surg, 40, pp.129~138 (2017)
- Ito K, "Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma", Ann Surg, 251, pp.675~681 (2010)
- Sakamoto Y, "Surgical management of infrahilar", suprapancreatic cholangiocarcinoma : an analysis of the surgical procedures, surgical margins, and survivals of 77 patients, 2010, pp.14, 335~343
- Endo I, "Clinical significance of intraoperative bileduct margin assessment for hilar cholangiocarcinoma", Ann Surg Oncol, 15, pp.2104~2112 (2008)
- Wakai T, "Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma", Cancer, 103, pp.1210~1216 (2005)
- Sasaki R, "Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma", World J Surg, 31, pp.1788~1796 (2007)
- Nakanishi Y, "Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma", J Hepatobiliary Pancreat Sci, 17, pp.166~173 (2010)
- Kim K, "Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer : a long-term single center experience", Am J Clin Oncol, 35, pp.136~140 (2012)
- Park JH, "Postoperative chemoradiotherapy for extrahepatic bile duct cancer", Int J Radiat Oncol Biol Phys, 79, pp.696~704 (2011)
- Kim JK, "CT analysis of postoperative tumor recurrence patterns in periampullary cancer", Abdom Imaging, 28, pp.384~391 (2003)
- de Castro SM, "Recurrent disease after microscopically radical(R0)resection of periampullary adenocarcinoma in patients without adjuvant therapy", J Gastrointest Surg, 8, pp.775~784 (2004)
- Oyasiji T, "Molecular targets in biliary carcinogenesis and implications for therapy", Oncologist, 20, pp.742~751 (2015)
- Marks EI, "Immunotherapeutic approaches in biliary tract carcinoma : current status and emerging strategies", World J Gastrointest Oncol, 7, pp.338~346 (2015)
- Kim YS, "Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma", Cancer Chemother Pharmacol, 77, pp.979~985 (2016)
- Kim TH, "Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer", Int J Radiat Oncol Biol Phys, 81, pp.853~859 (2011)
- Jang JY, "Actual long-term outcome of extrahepatic bile duct cancer after surgical resection", Ann Surg, 241, pp.77~84 (2005)
- Han IW, "Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin", HPB(Oxford), 16, pp.575~581 (2014)